Miami-Fort Lauderdale Area
Program Manager with 8+ years leading global medical device commercialization, regulated product delivery, and process improvement at scale. At Medtronic, drove PMO governance and commercialization readiness across 12+ international markets for the Hugo™ Surgical Robotics platform, a $500M+ program spanning Brazil, Mexico, Europe, India, and Panama, contributing to a $34M CAPEX scaling initiative that expanded global capacity. Currently seeking remote or hubrid Senior PM/ Program Manager roles in Medical devices, PMO, NPD/NPI, and commercial transformation. Based in South Florida I chose MedTech intentionally. Execution in this industry does not just move revenue. It changes patient outcomes. I build governance frameworks, launch playbooks, and portfolio systems that elevate teams, clarify risk, and enable sustainable scale. I have also co-led ERG initiatives and mentored junior PMs, reinforcing my belief that durable success comes from empowering people, not just managing timelines. What I bring: ♦ Surgical Robotics and Commercialization: Drove PMO governance and launch readiness across 12+ markets for Medtronic's Hugo™ platform, a $500M+ program. Built launch playbooks, Stage-Gate criteria, and portfolio dashboards supporting $34M in global expansion. ♦ Regulatory and Quality Execution: Delivered 95% on-time regulatory programs across ISO 13485, MDR, and UKCA frameworks for 50+ medical device manufacturers, improving forecast accuracy approximately 35% and accelerating approvals approximately 20%. ♦ Enterprise Technology and Software Delivery: Led a $1M+ commercial systems portfolio at LabConnect, delivering Salesforce and ERP integrations that accelerated response times 30%, reduced cycle time, and improved adoption through structured governance and stakeholder alignment. ♦ Program and Portfolio Leadership: Established Stage-Gate and portfolio governance models that improved forecast accuracy 35% to 45% and reduced launch delays 30% across regulated product environments. My approach blends engineering discipline with adaptive execution. I’ve standardized NPD cycles, mitigated $1.2M+ in supply chain risk, and mentored emerging program managers, building scalable frameworks that improve delivery consistency over time. Always glad to connect with leaders in MedTech program/portfolio delivery, Stage-Gate governance, and regulated product launches.
Driving clinical trial operations transformation at LabConnect, a global central laboratory services provider supporting pharmaceutical and medical device clinical trials, by strengthening portfolio governance, accelerating regulatory readiness, and scaling operational infrastructure critical to sponsor trial execution and device approval timelines. ♦ PORTFOLIO DELIVERY: Led $1M+ technology investment portfolio across 15+ cross-functional teams (Sales, Finance, IT, Commercial Operations), establishing stage-gate governance (program charters, RAID, dependency tracking, executive dashboards) that improved on-time delivery consistency by 40% and strengthened operational readiness for clinical trial sample processing, data integrity, and regulatory compliance requirements. ♦ OPERATIONAL READINESS: Delivered integrated commercial systems capability reducing clinical trial RFx response cycle time by 60%, enabling real-time visibility into laboratory service capacity (bioanalytical testing, sample chain-of-custody, compliance status per 21 CFR Part 11) and supporting $2M+ in accelerated contract opportunities with pharmaceutical and device sponsors requiring rapid trial initiation. ♦ PROCESS STANDARDIZATION: Redesigned Lead-to-Order workflows across Commercial, Sales, and Finance, implementing workflow automation and governance controls that improved quote-to-contract cycle time by 57% and eliminated $50K+ in operational bottlenecks, critical for supporting time-sensitive clinical trial procurement cycles where laboratory readiness directly impacts device approval timelines.
Led regulatory program delivery for BSI's medical device certification portfolio, managing concurrent ISO 13485, EU MDR, and UKCA compliance programs that enabled 50+ manufacturers to achieve and maintain US/EU/UK market access. ♦ PORTFOLIO DELIVERY: Managed 8 concurrent certification programs (combined value $3M+) for Class I–III device manufacturers, establishing integrated program plans, regulatory milestone gates (design dossier, technical file, notified body audits), and cross-functional dependency management across Product, IT, Regulatory, and Client Services, achieving 95% on-time delivery rate across multi-region submissions. ♦ GOVERNANCE & RISK: Owned operating cadence (steering committees, status reporting, RAID, change control) with Director-level sponsors, notified bodies, and regulatory authorities, driving proactive risk mitigation that reduced approval cycle time by 20% and improved audit readiness of technical documentation. ♦ DELIVERY OPERATIONS: Implemented portfolio infrastructure (capacity planning, budget tracking, forecasting, KPI dashboards in MS Project) to improve delivery visibility, increase forecasting accuracy by 35%, and enable rapid resource reallocation across technical writers, regulatory specialists, and quality auditors to protect critical-path certification timelines.
Drove MedTech program delivery for Medtronic's $500M+ Hugo™ Robotic Assisted Surgery platform, leading commercial readiness portfolio execution across 12+ multi-regional launches by establishing governance frameworks, accelerating regulatory pathways, and securing investment to scale commercialization capacity. ♦ PROGRAM GOVERNANCE: Established Stage-Gate operating cadence across 12+ launches and 8–12 concurrent readiness programs, implementing quality gates (regulatory submission, training certification, inventory positioning), dependency management, and Smartsheet/Microsoft Project dashboards with integrated risk registers, reducing status reporting cycle time by 40% and accelerating launch timelines by 25%. ♦ REGULATORY ACCELERATION: Streamlined FDA 510(k) and CE Mark regulatory pathways across Brazil, Mexico, and 5 European markets and compressed approval cycles for India and Panama market entries by 6–8 weeks by establishing cross-functional collaboration frameworks and weekly steering governance across Regulatory, Product, Supply Chain, Training, Service, Sales, and Marketing stakeholders. ♦ RESOURCE SCALING: Secured $34M+ in CAPEX through executive-sponsored business cases to close commercialization capacity gaps (training infrastructure, field inventory, service readiness), enabling 3x growth in concurrent market launches over 12 months and supporting Hugo™ platform expansion into new clinical applications.
Driving regulated commercialization execution for Medtronic’s Hugo™ surgical robotics platform by leading a global commercial readiness portfolio, scaling governance, and accelerating approvals as the platform expanded into new markets and clinical applications. ♦ PORTFOLIO DELIVERY: Directed 8–12 concurrent commercial readiness initiatives for Hugo™ NPI across global markets, leading matrixed stakeholders across Sales, Marketing, Product Management, Regulatory, Supply Chain, and Training through the full lifecycle from business case through post-launch optimization. ♦ GOVERNANCE SCALE: Implemented a Phase-Gate governance framework with standardized quality gates, decision criteria, integrated RAID, and cloud-based portfolio dashboards (with IT/Process Excellence), reducing launch delays by 30% and improving forecast accuracy by 45%. ♦ REGULATORY ACCELERATION: Established cross-functional collaboration frameworks and a weekly steering committee cadence that compressed approval timelines by 6–8 weeks for India and Panama launches, enabling earlier revenue capture and repeatable execution for future market entries.
Drove MedTech operations program delivery at Medtronic, leading cross-functional NPD execution for 12 new product introductions across Stapling and Hernia portfolios by scaling manufacturing readiness, de-risking supply chain strategy, and implementing operational governance frameworks that enabled $100M+ in product launches. ♦ NPD PROGRAM DELIVERY: Led execution for 12 NPD initiatives across Stapling and Hernia, managing $5M+ budgets and integrated RAID/dependency management across Manufacturing, R&D, Supply Chain, and Quality through design freeze, validation (IQ/OQ/PQ), and manufacturing transfer, delivering 10 of 12 programs on time and enabling $100M+ in commercial launch impact. ♦ PLANNING STANDARDIZATION: Standardized NPD planning and capacity forecasting by implementing enterprise assessment frameworks for materials readiness, resource allocation, and line speed optimization, reducing development cycle time by 15% and improving manufacturing forecast accuracy by 30%. ♦ RISK & COST OPTIMIZATION: Mitigated $1.5M+ in supply chain risk by reducing single-source dependencies by 60% and delivered $1.2M annual cost avoidance through Make vs. Buy methodology and ISO 13485-aligned supplier capability assessments across 15+ facilities, qualifying alternate sources and enabling multi-sourcing strategy for critical components.
Driving program-style quality delivery at Citilabs by building a scalable QA operating model, establishing governance and metrics, and partnering cross-functionally to improve product reliability and release predictability for a flagship analytics platform. ♦ QUALITY GOVERNANCE: Built and led a 12-person QA and data governance team, establishing validation cadence, KPI dashboards (accuracy, completion, productivity), and SLA-based controls to improve delivery predictability and enable data-driven executive resourcing decisions. ♦ PROCESS STANDARDIZATION: Redefined QA operating standards by redesigning training and validation workflows, reducing data errors by 35% and accelerating release cycles by 20% while maintaining compliance to commercial quality requirements. ♦ CROSS-FUNCTIONAL IMPROVEMENT: Partnered with Product and Engineering to translate customer feedback into a prioritized improvement roadmap, increasing customer satisfaction by 25% and reducing defects by 40% through defect-prevention and continuous improvement practices.